SYSTEMIC HEMODYNAMICS AND RENAL-FUNCTION DURING BRAIN NATRIURETIC PEPTIDE INFUSION IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：21

作者：

LAZZERI, C ^{[1
]}

FRANCHI, F ^{[1
]}

PORCIANI, C ^{[1
]}

FRONZAROLI, C ^{[1
]}

RAGGI, VC ^{[1
]}

DEFEO, ML ^{[1
]}

MANNELLI, M ^{[1
]}

CERSOSIMO, RM ^{[1
]}

LAVILLA, G ^{[1
]}

机构：

[1] UNIV FLORENCE,SCH MED,IST MED INTERNA,CARDIOVASC UNIT,I-50134 FLORENCE,ITALY

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1995年 / 8卷 / 08期

关键词：

BRAIN NATRIURETIC PEPTIDE; ESSENTIAL HYPERTENSION; RENAL FUNCTION; SODIUM EXCRETION; SYSTEMIC HEMODYNAMICS;

D O I：

10.1016/0895-7061(95)00147-H

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

We assessed the cardiovascular and renal effects of human brain natriuretic peptide (BNP) infused at a dose inducing an increase in plasma BNP to pathophysiologic levels, in eight hypertensive patients in a randomized, placebo-controlled, crossover study. Left ventricular performance, cardiac output (echocardiography), heart rate, arterial pressure, glomerular filtration rate (GFR; creatinine clearance), sodium excretion, intrarenal sodium handling (lithium clearance method), and urine flow rate were measured in the infusion and postinfusion periods (1 h each), together with plasma BNP and the urinary excretion rate of cGMP. Plasma BNP levels increased from 2.90 +/- 0.74 to 36.43 +/- 5.51 pmol/L (P < .01) at the end of the infusion and were still elevated at the end of the postinfusion period (7.03 +/- 1.41 pmol/L, P < .05). The urinary excretion of cGMP was also significantly higher during BNP infusion. Left ventricular performance, cardiac output, arterial pressure, and peripheral vascular resistance were not affected by BNP. Peptide infusion induced a significant increase in GFR (placebo, 115 +/- 24; BNP, 147 +/- 19 mL/min), sodium excretion (placebo, 129 +/- 40; BNP, 243 +/- 60 mu mol/min), and urine flow rate. All these effects were observed also in the postinfusion period. The natriuretic effect of BNP was attributable to both an increase in filtered sodium load and a reduction of distal sodium reabsorption. These results suggest that BNP may contribute to maintain renal function and sodium excretion in patients with essential hypertension.

引用

页码：799 / 807

页数：9

共 36 条

[1] Lang, Choy, Struthers, Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis, Clin Sci, 83, pp. 519-527, (1992)
[2] Hosoda, Nakao, Mukoyama, Et al., Expression of brain natriuretic peptide gene in human heart. Production in the ventricle, Hypertension, 17, pp. 1152-1156, (1991)
[3] Mukoyama, Nakao, Hosoda, Et al., Brain natriuretic peptide as a novel cardiac hormone in humans, J Clin Invest, 87, pp. 1402-1412, (1991)
[4] Saito, Nakao, Itoh, Et al., Brain natriuretic pep-tide is a novel cardiac hormone, Biochem Biophys Res Commun, 158, pp. 360-368, (1989)
[5] Sudoh, Kangawa, Minamino, Et al., A new natriuretic peptide in porcine brain, Nature, 332, pp. 78-81, (1988)
[6] Suga, Nakao, Hosoda, Et al., Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic pep-tide, Endocrinology, 130, pp. 229-239, (1992)
[7] Kenny, Bourne, Ingram, Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptors ligands by endopeptidase-24.11, Biochem J, 291, pp. 83-88, (1993)
[8] Schulz-Knappe, Honrath, Forssmann, Et al., Endogenous natriuretic peptides effect on collecting duct function in rat kidney, Am J Physiol, 259, pp. F415-F418, (1990)
[9] Gunning, Ballermann, Silva, Et al., Brain natriuretic peptide: interactions with renal ANP system, Am J Physiol, 258, pp. F467-F472, (1990)
[10] Kohno, Horio, Yokokawa, Et al., Brain natriuretic peptide as a cardiac hormone in essential hypertension, Am J Med, 92, pp. 29-34, (1992)

← 1 2 3 4 →